EUVIMEDEUVIMED entdecken
Validierungsstudie

Pulsed nicotine infusions as a model for smoking: validating a tool to explore nicotine thresholds in humans

Suprit Parida, R Ross MacLean, Ralitza Gueorguieva, Mehmet Sofuoglu

Psychopharmacology · 2024

DOI: 10.1007/s00213-024-06609-6 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Psychopharmacology, 2024. Verfasst von Suprit Parida und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA. Hauptthemen laut MEDLINE: Nicotine, Dose-Response Relationship, Drug, Heart Rate. Die Arbeit nennt 26 Literaturangaben. Gefördert von: U.S. Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RATIONALE: No previous studies examined the discriminative stimulus effects of intravenous (IV) nicotine in humans. OBJECTIVES: To evaluate a pulsed IV nicotine infusion procedure designed to mimic inhaled nicotine delivery and to identify a range of nicotine doses that may capture the threshold doses for the subjective and discriminative stimulus effects of nicotine. By determining these thresholds, we can gain valuable insights into the addictive threshold of nicotine. METHODS: Eleven participants had 2 Test Sessions following overnight abstinence from smoking. Test Session 1 examined participants' ability to discriminate 0.1 mg nicotine/pulse nicotine from saline. Test Session 2 examined if participants can discriminate 0.05, 0.025, and 0.0125 mg nicotine/pulse of nicotine from saline. These nicotine doses were delivered as a cluster of 4 pulsed-nicotine infusions of 2-second duration with a 28-second interval between each pulse. RESULTS: The lowest doses of nicotine that produced greater responses than saline for discrimination, subjective effects, and heart rate ranged from 0.05 to 0.1 mg nicotine/pulse. CONCLUSIONS: These findings support the validity of our pulsed-infusion procedure as a model for nicotine delivery by smoking and its utility in examining factors that may impact the addictive threshold of nicotine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NicotineDose-Response Relationship, DrugHeart RateHumansMaleAdultFemaleInfusions, IntravenousYoung AdultSmokingNicotinic AgonistsDiscrimination, Psychological

Stichwörter der Autor:innen

NicotineNicotine discriminationNicotine reductionPulsed-infusion

Substanzen

NicotineNicotinic Agonists

Autor:innen und Institutionen

  • Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA.
  • VA Connecticut Healthcare System, West Haven, CT, USA.
  • Department of Biostatistics, Yale University School of Public Health, New Haven, CT, USA.
  • Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA. Mehmet.sofoglu@yale.edu.
  • VA Connecticut Healthcare System, West Haven, CT, USA. Mehmet.sofoglu@yale.edu.
  • Department of Psychiatry, Yale University, VA Connecticut Healthcare System, 950 Campbell Ave., 151D, West Haven, CT, 06516, USA. Mehmet.sofoglu@yale.edu.

Förderung

  • U.S. Department of Veterans Affairs

Zitieren

APA

Parida, S., MacLean, R. R., Gueorguieva, R., & Sofuoglu, M. (2024). Pulsed nicotine infusions as a model for smoking: validating a tool to explore nicotine thresholds in humans. Psychopharmacology. https://doi.org/10.1007/s00213-024-06609-6

Vancouver

Parida S, MacLean RR, Gueorguieva R, Sofuoglu M. Pulsed nicotine infusions as a model for smoking: validating a tool to explore nicotine thresholds in humans. Psychopharmacology. 2024. doi:10.1007/s00213-024-06609-6

BibTeX
@article{Parida2024,
  author = {Parida, Suprit and MacLean, R Ross and Gueorguieva, Ralitza and Sofuoglu, Mehmet},
  title = {Pulsed nicotine infusions as a model for smoking: validating a tool to explore nicotine thresholds in humans},
  journal = {Psychopharmacology},
  year = {2024},
  doi = {10.1007/s00213-024-06609-6}
}
Kostenlos starten →